Medical Care
Global Stem Cell Therapy Market Research Report 2026
- Jan 17, 26
- ID: 688017
- Pages: 139
- Figures: 135
- Views: 5
This report delivers a comprehensive overview of the global Stem Cell Therapy market, with both quantitative and qualitative analyses, to help readers develop growth strategies, assess the competitive landscape, evaluate their position in the current market, and make informed business decisions regarding Stem Cell Therapy. The Stem Cell Therapy market size, estimates, and forecasts are provided in terms of revenue (US$ millions), with 2025 as the base year and historical and forecast data for 2021–2032.
The report segments the global Stem Cell Therapy market comprehensively. Regional market sizes by Type, by Application, , and by player are also provided. For deeper insight, the report profiles the competitive landscape, key competitors, and their respective market rankings, and discusses technological trends and new product developments.
This report will assist Stem Cell Therapy manufacturers, new entrants, and companies across the industry value chain with information on revenues, sales volume, and average prices for the overall market and its sub-segments, by company, by Type, by Application, and by region.
Market Segmentation
By Company
Medipost
Theracell Advanced Biotechnology
Nature Cell
Stempeutics
Regeneus
Bluebird bio, Inc
NIPRO
Kyowa Kirin
CorestemChemon Inc.
ANTEROGEN.CO., LTD.
Holostem
NuVasive
JCR Pharmaceutical
Pharmicell
Medi-post
Anterogen
Takeda (TiGenix)
Segment by Type
Allogeneic Stem Cell Therapies
Autologous Stem Cell Therapies
Segment by Application
Neurodegenerative Diseases
Cardiovascular Disorders
Autoimmune Conditions
Orthopedic Injuries
Cancer
Others
By Region
North America
U.S.
Canada
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia & New Zealand
Rest of Asia
Europe
Germany
France
U.K.
Italy
Ireland
Russia
Rest of Europe
Latin America
Mexico
Brazil
Argentina
Rest of Latin America
Middle East & Africa
Israel
United Arab Emirates (UAE)
Saudi Arabia
Rest of MEA
Chapter Outline
Chapter 1: Defines the scope of the report and presents an executive summary of market segments (by Type, by Application, , etc.), including the size of each segment and its future growth potential. It offers a high-level view of the current market and its likely evolution in the short, medium, and long term.
Chapter 2: Summarizes global and regional market size and outlines market dynamics and recent developments, including key drivers, restraints, challenges and risks for industry participants, and relevant policy analysis.
Chapter 3: Provides a detailed view of the competitive landscape for Stem Cell Therapy companies, covering revenue share, development plans, and mergers and acquisitions.
Chapter 4: Analyzes segments by Type, detailing the size and growth potential of each segment to help readers identify blue-ocean opportunities.
Chapter 5: Analyzes segments by Application, detailing the size and growth potential of each downstream segment to help readers identify blue-ocean opportunities.
Chapter 6–10: Regional deep dives (North America, Europe, Asia Pacific, Latin America, Middle East & Africa) broken down by country. Each chapter quantifies market size and growth potential by region and key countries, and outlines market development, outlook, addressable space, and capacity.
Chapter 11: Profiles key players, presenting essential information on leading companies, including product/ service offerings, revenue, gross margin, product introductions/portfolios, recent developments, etc.
Chapter 12: Key findings and conclusions of the report.
The report segments the global Stem Cell Therapy market comprehensively. Regional market sizes by Type, by Application, , and by player are also provided. For deeper insight, the report profiles the competitive landscape, key competitors, and their respective market rankings, and discusses technological trends and new product developments.
This report will assist Stem Cell Therapy manufacturers, new entrants, and companies across the industry value chain with information on revenues, sales volume, and average prices for the overall market and its sub-segments, by company, by Type, by Application, and by region.
Market Segmentation
By Company
Medipost
Theracell Advanced Biotechnology
Nature Cell
Stempeutics
Regeneus
Bluebird bio, Inc
NIPRO
Kyowa Kirin
CorestemChemon Inc.
ANTEROGEN.CO., LTD.
Holostem
NuVasive
JCR Pharmaceutical
Pharmicell
Medi-post
Anterogen
Takeda (TiGenix)
Segment by Type
Allogeneic Stem Cell Therapies
Autologous Stem Cell Therapies
Segment by Application
Neurodegenerative Diseases
Cardiovascular Disorders
Autoimmune Conditions
Orthopedic Injuries
Cancer
Others
By Region
North America
U.S.
Canada
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia & New Zealand
Rest of Asia
Europe
Germany
France
U.K.
Italy
Ireland
Russia
Rest of Europe
Latin America
Mexico
Brazil
Argentina
Rest of Latin America
Middle East & Africa
Israel
United Arab Emirates (UAE)
Saudi Arabia
Rest of MEA
Chapter Outline
Chapter 1: Defines the scope of the report and presents an executive summary of market segments (by Type, by Application, , etc.), including the size of each segment and its future growth potential. It offers a high-level view of the current market and its likely evolution in the short, medium, and long term.
Chapter 2: Summarizes global and regional market size and outlines market dynamics and recent developments, including key drivers, restraints, challenges and risks for industry participants, and relevant policy analysis.
Chapter 3: Provides a detailed view of the competitive landscape for Stem Cell Therapy companies, covering revenue share, development plans, and mergers and acquisitions.
Chapter 4: Analyzes segments by Type, detailing the size and growth potential of each segment to help readers identify blue-ocean opportunities.
Chapter 5: Analyzes segments by Application, detailing the size and growth potential of each downstream segment to help readers identify blue-ocean opportunities.
Chapter 6–10: Regional deep dives (North America, Europe, Asia Pacific, Latin America, Middle East & Africa) broken down by country. Each chapter quantifies market size and growth potential by region and key countries, and outlines market development, outlook, addressable space, and capacity.
Chapter 11: Profiles key players, presenting essential information on leading companies, including product/ service offerings, revenue, gross margin, product introductions/portfolios, recent developments, etc.
Chapter 12: Key findings and conclusions of the report.
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Stem Cell Therapy Market Size Growth Rate by Type: 2021 vs 2025 vs 2032
1.2.2 Allogeneic Stem Cell Therapies
1.2.3 Autologous Stem Cell Therapies
1.3 Market by Application
1.3.1 Global Stem Cell Therapy Market Growth by Application: 2021 vs 2025 vs 2032
1.3.2 Neurodegenerative Diseases
1.3.3 Cardiovascular Disorders
1.3.4 Autoimmune Conditions
1.3.5 Orthopedic Injuries
1.3.6 Cancer
1.3.7 Others
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global Stem Cell Therapy Market Perspective (2021–2032)
2.2 Global Stem Cell Therapy Growth Trends by Region
2.2.1 Global Stem Cell Therapy Market Size by Region: 2021 vs 2025 vs 2032
2.2.2 Stem Cell Therapy Historic Market Size by Region (2021–2026)
2.2.3 Stem Cell Therapy Forecasted Market Size by Region (2027–2032)
2.3 Stem Cell Therapy Market Dynamics
2.3.1 Stem Cell Therapy Industry Trends
2.3.2 Stem Cell Therapy Market Drivers
2.3.3 Stem Cell Therapy Market Challenges
2.3.4 Stem Cell Therapy Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Stem Cell Therapy Players by Revenue
3.1.1 Global Top Stem Cell Therapy Players by Revenue (2021–2026)
3.1.2 Global Stem Cell Therapy Revenue Market Share by Players (2021–2026)
3.2 Global Top Stem Cell Therapy Players Market Share by Company Tier (Tier 1, Tier 2, Tier 3)
3.3 Global Key Players Ranking by Stem Cell Therapy Revenue
3.4 Global Stem Cell Therapy Market Concentration Ratio
3.4.1 Global Stem Cell Therapy Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Stem Cell Therapy Revenue in 2025
3.5 Global Key Players of Stem Cell Therapy Head Offices and Areas Served
3.6 Global Key Players of Stem Cell Therapy, Products and Applications
3.7 Global Key Players of Stem Cell Therapy, Date of General Availability (GA)
3.8 Mergers and Acquisitions, Expansion Plans
4 Stem Cell Therapy Breakdown Data by Type
4.1 Global Stem Cell Therapy Historic Market Size by Type (2021–2026)
4.2 Global Stem Cell Therapy Forecasted Market Size by Type (2027–2032)
5 Stem Cell Therapy Breakdown Data by Application
5.1 Global Stem Cell Therapy Historic Market Size by Application (2021–2026)
5.2 Global Stem Cell Therapy Forecasted Market Size by Application (2027–2032)
6 North America
6.1 North America Stem Cell Therapy Market Size (2021–2032)
6.2 North America Stem Cell Therapy Market Growth Rate by Country: 2021 vs 2025 vs 2032
6.3 North America Stem Cell Therapy Market Size by Country (2021–2026)
6.4 North America Stem Cell Therapy Market Size by Country (2027–2032)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Stem Cell Therapy Market Size (2021–2032)
7.2 Europe Stem Cell Therapy Market Growth Rate by Country: 2021 vs 2025 vs 2032
7.3 Europe Stem Cell Therapy Market Size by Country (2021–2026)
7.4 Europe Stem Cell Therapy Market Size by Country (2027–2032)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Ireland
8 Asia-Pacific
8.1 Asia-Pacific Stem Cell Therapy Market Size (2021–2032)
8.2 Asia-Pacific Stem Cell Therapy Market Growth Rate by Region: 2021 vs 2025 vs 2032
8.3 Asia-Pacific Stem Cell Therapy Market Size by Region (2021–2026)
8.4 Asia-Pacific Stem Cell Therapy Market Size by Region (2027–2032)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia & New Zealand
9 Latin America
9.1 Latin America Stem Cell Therapy Market Size (2021–2032)
9.2 Latin America Stem Cell Therapy Market Growth Rate by Country: 2021 vs 2025 vs 2032
9.3 Latin America Stem Cell Therapy Market Size by Country (2021–2026)
9.4 Latin America Stem Cell Therapy Market Size by Country (2027–2032)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Stem Cell Therapy Market Size (2021–2032)
10.2 Middle East & Africa Stem Cell Therapy Market Growth Rate by Country: 2021 vs 2025 vs 2032
10.3 Middle East & Africa Stem Cell Therapy Market Size by Country (2021–2026)
10.4 Middle East & Africa Stem Cell Therapy Market Size by Country (2027–2032)
10.5 Israel
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Medipost
11.1.1 Medipost Company Details
11.1.2 Medipost Business Overview
11.1.3 Medipost Stem Cell Therapy Introduction
11.1.4 Medipost Revenue in Stem Cell Therapy Business (2021–2026)
11.1.5 Medipost Recent Development
11.2 Theracell Advanced Biotechnology
11.2.1 Theracell Advanced Biotechnology Company Details
11.2.2 Theracell Advanced Biotechnology Business Overview
11.2.3 Theracell Advanced Biotechnology Stem Cell Therapy Introduction
11.2.4 Theracell Advanced Biotechnology Revenue in Stem Cell Therapy Business (2021–2026)
11.2.5 Theracell Advanced Biotechnology Recent Development
11.3 Nature Cell
11.3.1 Nature Cell Company Details
11.3.2 Nature Cell Business Overview
11.3.3 Nature Cell Stem Cell Therapy Introduction
11.3.4 Nature Cell Revenue in Stem Cell Therapy Business (2021–2026)
11.3.5 Nature Cell Recent Development
11.4 Stempeutics
11.4.1 Stempeutics Company Details
11.4.2 Stempeutics Business Overview
11.4.3 Stempeutics Stem Cell Therapy Introduction
11.4.4 Stempeutics Revenue in Stem Cell Therapy Business (2021–2026)
11.4.5 Stempeutics Recent Development
11.5 Regeneus
11.5.1 Regeneus Company Details
11.5.2 Regeneus Business Overview
11.5.3 Regeneus Stem Cell Therapy Introduction
11.5.4 Regeneus Revenue in Stem Cell Therapy Business (2021–2026)
11.5.5 Regeneus Recent Development
11.6 Bluebird bio, Inc
11.6.1 Bluebird bio, Inc Company Details
11.6.2 Bluebird bio, Inc Business Overview
11.6.3 Bluebird bio, Inc Stem Cell Therapy Introduction
11.6.4 Bluebird bio, Inc Revenue in Stem Cell Therapy Business (2021–2026)
11.6.5 Bluebird bio, Inc Recent Development
11.7 NIPRO
11.7.1 NIPRO Company Details
11.7.2 NIPRO Business Overview
11.7.3 NIPRO Stem Cell Therapy Introduction
11.7.4 NIPRO Revenue in Stem Cell Therapy Business (2021–2026)
11.7.5 NIPRO Recent Development
11.8 Kyowa Kirin
11.8.1 Kyowa Kirin Company Details
11.8.2 Kyowa Kirin Business Overview
11.8.3 Kyowa Kirin Stem Cell Therapy Introduction
11.8.4 Kyowa Kirin Revenue in Stem Cell Therapy Business (2021–2026)
11.8.5 Kyowa Kirin Recent Development
11.9 CorestemChemon Inc.
11.9.1 CorestemChemon Inc. Company Details
11.9.2 CorestemChemon Inc. Business Overview
11.9.3 CorestemChemon Inc. Stem Cell Therapy Introduction
11.9.4 CorestemChemon Inc. Revenue in Stem Cell Therapy Business (2021–2026)
11.9.5 CorestemChemon Inc. Recent Development
11.10 ANTEROGEN.CO., LTD.
11.10.1 ANTEROGEN.CO., LTD. Company Details
11.10.2 ANTEROGEN.CO., LTD. Business Overview
11.10.3 ANTEROGEN.CO., LTD. Stem Cell Therapy Introduction
11.10.4 ANTEROGEN.CO., LTD. Revenue in Stem Cell Therapy Business (2021–2026)
11.10.5 ANTEROGEN.CO., LTD. Recent Development
11.11 Holostem
11.11.1 Holostem Company Details
11.11.2 Holostem Business Overview
11.11.3 Holostem Stem Cell Therapy Introduction
11.11.4 Holostem Revenue in Stem Cell Therapy Business (2021–2026)
11.11.5 Holostem Recent Development
11.12 NuVasive
11.12.1 NuVasive Company Details
11.12.2 NuVasive Business Overview
11.12.3 NuVasive Stem Cell Therapy Introduction
11.12.4 NuVasive Revenue in Stem Cell Therapy Business (2021–2026)
11.12.5 NuVasive Recent Development
11.13 JCR Pharmaceutical
11.13.1 JCR Pharmaceutical Company Details
11.13.2 JCR Pharmaceutical Business Overview
11.13.3 JCR Pharmaceutical Stem Cell Therapy Introduction
11.13.4 JCR Pharmaceutical Revenue in Stem Cell Therapy Business (2021–2026)
11.13.5 JCR Pharmaceutical Recent Development
11.14 Pharmicell
11.14.1 Pharmicell Company Details
11.14.2 Pharmicell Business Overview
11.14.3 Pharmicell Stem Cell Therapy Introduction
11.14.4 Pharmicell Revenue in Stem Cell Therapy Business (2021–2026)
11.14.5 Pharmicell Recent Development
11.15 Medi-post
11.15.1 Medi-post Company Details
11.15.2 Medi-post Business Overview
11.15.3 Medi-post Stem Cell Therapy Introduction
11.15.4 Medi-post Revenue in Stem Cell Therapy Business (2021–2026)
11.15.5 Medi-post Recent Development
11.16 Anterogen
11.16.1 Anterogen Company Details
11.16.2 Anterogen Business Overview
11.16.3 Anterogen Stem Cell Therapy Introduction
11.16.4 Anterogen Revenue in Stem Cell Therapy Business (2021–2026)
11.16.5 Anterogen Recent Development
11.17 Takeda (TiGenix)
11.17.1 Takeda (TiGenix) Company Details
11.17.2 Takeda (TiGenix) Business Overview
11.17.3 Takeda (TiGenix) Stem Cell Therapy Introduction
11.17.4 Takeda (TiGenix) Revenue in Stem Cell Therapy Business (2021–2026)
11.17.5 Takeda (TiGenix) Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.1.1 Research Programs/Design
13.1.1.2 Market Size Estimation
13.1.1.3 Market Breakdown and Data Triangulation
13.1.2 Data Source
13.1.2.1 Secondary Sources
13.1.2.2 Primary Sources
13.2 Author Details
13.3 Disclaimer
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Stem Cell Therapy Market Size Growth Rate by Type: 2021 vs 2025 vs 2032
1.2.2 Allogeneic Stem Cell Therapies
1.2.3 Autologous Stem Cell Therapies
1.3 Market by Application
1.3.1 Global Stem Cell Therapy Market Growth by Application: 2021 vs 2025 vs 2032
1.3.2 Neurodegenerative Diseases
1.3.3 Cardiovascular Disorders
1.3.4 Autoimmune Conditions
1.3.5 Orthopedic Injuries
1.3.6 Cancer
1.3.7 Others
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global Stem Cell Therapy Market Perspective (2021–2032)
2.2 Global Stem Cell Therapy Growth Trends by Region
2.2.1 Global Stem Cell Therapy Market Size by Region: 2021 vs 2025 vs 2032
2.2.2 Stem Cell Therapy Historic Market Size by Region (2021–2026)
2.2.3 Stem Cell Therapy Forecasted Market Size by Region (2027–2032)
2.3 Stem Cell Therapy Market Dynamics
2.3.1 Stem Cell Therapy Industry Trends
2.3.2 Stem Cell Therapy Market Drivers
2.3.3 Stem Cell Therapy Market Challenges
2.3.4 Stem Cell Therapy Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Stem Cell Therapy Players by Revenue
3.1.1 Global Top Stem Cell Therapy Players by Revenue (2021–2026)
3.1.2 Global Stem Cell Therapy Revenue Market Share by Players (2021–2026)
3.2 Global Top Stem Cell Therapy Players Market Share by Company Tier (Tier 1, Tier 2, Tier 3)
3.3 Global Key Players Ranking by Stem Cell Therapy Revenue
3.4 Global Stem Cell Therapy Market Concentration Ratio
3.4.1 Global Stem Cell Therapy Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Stem Cell Therapy Revenue in 2025
3.5 Global Key Players of Stem Cell Therapy Head Offices and Areas Served
3.6 Global Key Players of Stem Cell Therapy, Products and Applications
3.7 Global Key Players of Stem Cell Therapy, Date of General Availability (GA)
3.8 Mergers and Acquisitions, Expansion Plans
4 Stem Cell Therapy Breakdown Data by Type
4.1 Global Stem Cell Therapy Historic Market Size by Type (2021–2026)
4.2 Global Stem Cell Therapy Forecasted Market Size by Type (2027–2032)
5 Stem Cell Therapy Breakdown Data by Application
5.1 Global Stem Cell Therapy Historic Market Size by Application (2021–2026)
5.2 Global Stem Cell Therapy Forecasted Market Size by Application (2027–2032)
6 North America
6.1 North America Stem Cell Therapy Market Size (2021–2032)
6.2 North America Stem Cell Therapy Market Growth Rate by Country: 2021 vs 2025 vs 2032
6.3 North America Stem Cell Therapy Market Size by Country (2021–2026)
6.4 North America Stem Cell Therapy Market Size by Country (2027–2032)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Stem Cell Therapy Market Size (2021–2032)
7.2 Europe Stem Cell Therapy Market Growth Rate by Country: 2021 vs 2025 vs 2032
7.3 Europe Stem Cell Therapy Market Size by Country (2021–2026)
7.4 Europe Stem Cell Therapy Market Size by Country (2027–2032)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Ireland
8 Asia-Pacific
8.1 Asia-Pacific Stem Cell Therapy Market Size (2021–2032)
8.2 Asia-Pacific Stem Cell Therapy Market Growth Rate by Region: 2021 vs 2025 vs 2032
8.3 Asia-Pacific Stem Cell Therapy Market Size by Region (2021–2026)
8.4 Asia-Pacific Stem Cell Therapy Market Size by Region (2027–2032)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia & New Zealand
9 Latin America
9.1 Latin America Stem Cell Therapy Market Size (2021–2032)
9.2 Latin America Stem Cell Therapy Market Growth Rate by Country: 2021 vs 2025 vs 2032
9.3 Latin America Stem Cell Therapy Market Size by Country (2021–2026)
9.4 Latin America Stem Cell Therapy Market Size by Country (2027–2032)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Stem Cell Therapy Market Size (2021–2032)
10.2 Middle East & Africa Stem Cell Therapy Market Growth Rate by Country: 2021 vs 2025 vs 2032
10.3 Middle East & Africa Stem Cell Therapy Market Size by Country (2021–2026)
10.4 Middle East & Africa Stem Cell Therapy Market Size by Country (2027–2032)
10.5 Israel
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Medipost
11.1.1 Medipost Company Details
11.1.2 Medipost Business Overview
11.1.3 Medipost Stem Cell Therapy Introduction
11.1.4 Medipost Revenue in Stem Cell Therapy Business (2021–2026)
11.1.5 Medipost Recent Development
11.2 Theracell Advanced Biotechnology
11.2.1 Theracell Advanced Biotechnology Company Details
11.2.2 Theracell Advanced Biotechnology Business Overview
11.2.3 Theracell Advanced Biotechnology Stem Cell Therapy Introduction
11.2.4 Theracell Advanced Biotechnology Revenue in Stem Cell Therapy Business (2021–2026)
11.2.5 Theracell Advanced Biotechnology Recent Development
11.3 Nature Cell
11.3.1 Nature Cell Company Details
11.3.2 Nature Cell Business Overview
11.3.3 Nature Cell Stem Cell Therapy Introduction
11.3.4 Nature Cell Revenue in Stem Cell Therapy Business (2021–2026)
11.3.5 Nature Cell Recent Development
11.4 Stempeutics
11.4.1 Stempeutics Company Details
11.4.2 Stempeutics Business Overview
11.4.3 Stempeutics Stem Cell Therapy Introduction
11.4.4 Stempeutics Revenue in Stem Cell Therapy Business (2021–2026)
11.4.5 Stempeutics Recent Development
11.5 Regeneus
11.5.1 Regeneus Company Details
11.5.2 Regeneus Business Overview
11.5.3 Regeneus Stem Cell Therapy Introduction
11.5.4 Regeneus Revenue in Stem Cell Therapy Business (2021–2026)
11.5.5 Regeneus Recent Development
11.6 Bluebird bio, Inc
11.6.1 Bluebird bio, Inc Company Details
11.6.2 Bluebird bio, Inc Business Overview
11.6.3 Bluebird bio, Inc Stem Cell Therapy Introduction
11.6.4 Bluebird bio, Inc Revenue in Stem Cell Therapy Business (2021–2026)
11.6.5 Bluebird bio, Inc Recent Development
11.7 NIPRO
11.7.1 NIPRO Company Details
11.7.2 NIPRO Business Overview
11.7.3 NIPRO Stem Cell Therapy Introduction
11.7.4 NIPRO Revenue in Stem Cell Therapy Business (2021–2026)
11.7.5 NIPRO Recent Development
11.8 Kyowa Kirin
11.8.1 Kyowa Kirin Company Details
11.8.2 Kyowa Kirin Business Overview
11.8.3 Kyowa Kirin Stem Cell Therapy Introduction
11.8.4 Kyowa Kirin Revenue in Stem Cell Therapy Business (2021–2026)
11.8.5 Kyowa Kirin Recent Development
11.9 CorestemChemon Inc.
11.9.1 CorestemChemon Inc. Company Details
11.9.2 CorestemChemon Inc. Business Overview
11.9.3 CorestemChemon Inc. Stem Cell Therapy Introduction
11.9.4 CorestemChemon Inc. Revenue in Stem Cell Therapy Business (2021–2026)
11.9.5 CorestemChemon Inc. Recent Development
11.10 ANTEROGEN.CO., LTD.
11.10.1 ANTEROGEN.CO., LTD. Company Details
11.10.2 ANTEROGEN.CO., LTD. Business Overview
11.10.3 ANTEROGEN.CO., LTD. Stem Cell Therapy Introduction
11.10.4 ANTEROGEN.CO., LTD. Revenue in Stem Cell Therapy Business (2021–2026)
11.10.5 ANTEROGEN.CO., LTD. Recent Development
11.11 Holostem
11.11.1 Holostem Company Details
11.11.2 Holostem Business Overview
11.11.3 Holostem Stem Cell Therapy Introduction
11.11.4 Holostem Revenue in Stem Cell Therapy Business (2021–2026)
11.11.5 Holostem Recent Development
11.12 NuVasive
11.12.1 NuVasive Company Details
11.12.2 NuVasive Business Overview
11.12.3 NuVasive Stem Cell Therapy Introduction
11.12.4 NuVasive Revenue in Stem Cell Therapy Business (2021–2026)
11.12.5 NuVasive Recent Development
11.13 JCR Pharmaceutical
11.13.1 JCR Pharmaceutical Company Details
11.13.2 JCR Pharmaceutical Business Overview
11.13.3 JCR Pharmaceutical Stem Cell Therapy Introduction
11.13.4 JCR Pharmaceutical Revenue in Stem Cell Therapy Business (2021–2026)
11.13.5 JCR Pharmaceutical Recent Development
11.14 Pharmicell
11.14.1 Pharmicell Company Details
11.14.2 Pharmicell Business Overview
11.14.3 Pharmicell Stem Cell Therapy Introduction
11.14.4 Pharmicell Revenue in Stem Cell Therapy Business (2021–2026)
11.14.5 Pharmicell Recent Development
11.15 Medi-post
11.15.1 Medi-post Company Details
11.15.2 Medi-post Business Overview
11.15.3 Medi-post Stem Cell Therapy Introduction
11.15.4 Medi-post Revenue in Stem Cell Therapy Business (2021–2026)
11.15.5 Medi-post Recent Development
11.16 Anterogen
11.16.1 Anterogen Company Details
11.16.2 Anterogen Business Overview
11.16.3 Anterogen Stem Cell Therapy Introduction
11.16.4 Anterogen Revenue in Stem Cell Therapy Business (2021–2026)
11.16.5 Anterogen Recent Development
11.17 Takeda (TiGenix)
11.17.1 Takeda (TiGenix) Company Details
11.17.2 Takeda (TiGenix) Business Overview
11.17.3 Takeda (TiGenix) Stem Cell Therapy Introduction
11.17.4 Takeda (TiGenix) Revenue in Stem Cell Therapy Business (2021–2026)
11.17.5 Takeda (TiGenix) Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.1.1 Research Programs/Design
13.1.1.2 Market Size Estimation
13.1.1.3 Market Breakdown and Data Triangulation
13.1.2 Data Source
13.1.2.1 Secondary Sources
13.1.2.2 Primary Sources
13.2 Author Details
13.3 Disclaimer
List of Tables
Table 1. Global Stem Cell Therapy Market Size Growth Rate by Type (US$ Million): 2021 vs 2025 vs 2032
Table 2. Key Players of Allogeneic Stem Cell Therapies
Table 3. Key Players of Autologous Stem Cell Therapies
Table 4. Global Stem Cell Therapy Market Size Growth by Application (US$ Million): 2021 vs 2025 vs 2032
Table 5. Global Stem Cell Therapy Market Size by Region (US$ Million): 2021 vs 2025 vs 2032
Table 6. Global Stem Cell Therapy Market Size by Region (US$ Million), 2021–2026
Table 7. Global Stem Cell Therapy Market Share by Region (2021–2026)
Table 8. Global Stem Cell Therapy Forecasted Market Size by Region (US$ Million), 2027–2032
Table 9. Global Stem Cell Therapy Market Share by Region (2027–2032)
Table 10. Stem Cell Therapy Market Trends
Table 11. Stem Cell Therapy Market Drivers
Table 12. Stem Cell Therapy Market Challenges
Table 13. Stem Cell Therapy Market Restraints
Table 14. Global Stem Cell Therapy Revenue by Players (US$ Million), 2021–2026
Table 15. Global Stem Cell Therapy Market Share by Players (2021–2026)
Table 16. Global Top Stem Cell Therapy Players by Tier (Tier 1, Tier 2, and Tier 3), based on Stem Cell Therapy Revenue, 2025
Table 17. Ranking of Global Top Stem Cell Therapy Companies by Revenue (US$ Million) in 2025
Table 18. Global 5 Largest Players Market Share by Stem Cell Therapy Revenue (CR5 and HHI), 2021–2026
Table 19. Global Key Players of Stem Cell Therapy, Headquarters and Area Served
Table 20. Global Key Players of Stem Cell Therapy, Products and Applications
Table 21. Global Key Players of Stem Cell Therapy, Date of General Availability (GA)
Table 22. Mergers and Acquisitions, Expansion Plans
Table 23. Global Stem Cell Therapy Market Size by Type (US$ Million), 2021–2026
Table 24. Global Stem Cell Therapy Revenue Market Share by Type (2021–2026)
Table 25. Global Stem Cell Therapy Forecasted Market Size by Type (US$ Million), 2027–2032
Table 26. Global Stem Cell Therapy Revenue Market Share by Type (2027–2032)
Table 27. Global Stem Cell Therapy Market Size by Application (US$ Million), 2021–2026
Table 28. Global Stem Cell Therapy Revenue Market Share by Application (2021–2026)
Table 29. Global Stem Cell Therapy Forecasted Market Size by Application (US$ Million), 2027–2032
Table 30. Global Stem Cell Therapy Revenue Market Share by Application (2027–2032)
Table 31. North America Stem Cell Therapy Market Size Growth Rate by Country (US$ Million): 2021 vs 2025 vs 2032
Table 32. North America Stem Cell Therapy Market Size by Country (US$ Million), 2021–2026
Table 33. North America Stem Cell Therapy Market Size by Country (US$ Million), 2027–2032
Table 34. Europe Stem Cell Therapy Market Size Growth Rate by Country (US$ Million): 2021 vs 2025 vs 2032
Table 35. Europe Stem Cell Therapy Market Size by Country (US$ Million), 2021–2026
Table 36. Europe Stem Cell Therapy Market Size by Country (US$ Million), 2027–2032
Table 37. Asia-Pacific Stem Cell Therapy Market Size Growth Rate by Region (US$ Million): 2021 vs 2025 vs 2032
Table 38. Asia-Pacific Stem Cell Therapy Market Size by Region (US$ Million), 2021–2026
Table 39. Asia-Pacific Stem Cell Therapy Market Size by Region (US$ Million), 2027–2032
Table 40. Latin America Stem Cell Therapy Market Size Growth Rate by Country (US$ Million): 2021 vs 2025 vs 2032
Table 41. Latin America Stem Cell Therapy Market Size by Country (US$ Million), 2021–2026
Table 42. Latin America Stem Cell Therapy Market Size by Country (US$ Million), 2027–2032
Table 43. Middle East & Africa Stem Cell Therapy Market Size Growth Rate by Country (US$ Million): 2021 vs 2025 vs 2032
Table 44. Middle East & Africa Stem Cell Therapy Market Size by Country (US$ Million), 2021–2026
Table 45. Middle East & Africa Stem Cell Therapy Market Size by Country (US$ Million), 2027–2032
Table 46. Medipost Company Details
Table 47. Medipost Business Overview
Table 48. Medipost Stem Cell Therapy Product
Table 49. Medipost Revenue in Stem Cell Therapy Business (US$ Million), 2021–2026
Table 50. Medipost Recent Development
Table 51. Theracell Advanced Biotechnology Company Details
Table 52. Theracell Advanced Biotechnology Business Overview
Table 53. Theracell Advanced Biotechnology Stem Cell Therapy Product
Table 54. Theracell Advanced Biotechnology Revenue in Stem Cell Therapy Business (US$ Million), 2021–2026
Table 55. Theracell Advanced Biotechnology Recent Development
Table 56. Nature Cell Company Details
Table 57. Nature Cell Business Overview
Table 58. Nature Cell Stem Cell Therapy Product
Table 59. Nature Cell Revenue in Stem Cell Therapy Business (US$ Million), 2021–2026
Table 60. Nature Cell Recent Development
Table 61. Stempeutics Company Details
Table 62. Stempeutics Business Overview
Table 63. Stempeutics Stem Cell Therapy Product
Table 64. Stempeutics Revenue in Stem Cell Therapy Business (US$ Million), 2021–2026
Table 65. Stempeutics Recent Development
Table 66. Regeneus Company Details
Table 67. Regeneus Business Overview
Table 68. Regeneus Stem Cell Therapy Product
Table 69. Regeneus Revenue in Stem Cell Therapy Business (US$ Million), 2021–2026
Table 70. Regeneus Recent Development
Table 71. Bluebird bio, Inc Company Details
Table 72. Bluebird bio, Inc Business Overview
Table 73. Bluebird bio, Inc Stem Cell Therapy Product
Table 74. Bluebird bio, Inc Revenue in Stem Cell Therapy Business (US$ Million), 2021–2026
Table 75. Bluebird bio, Inc Recent Development
Table 76. NIPRO Company Details
Table 77. NIPRO Business Overview
Table 78. NIPRO Stem Cell Therapy Product
Table 79. NIPRO Revenue in Stem Cell Therapy Business (US$ Million), 2021–2026
Table 80. NIPRO Recent Development
Table 81. Kyowa Kirin Company Details
Table 82. Kyowa Kirin Business Overview
Table 83. Kyowa Kirin Stem Cell Therapy Product
Table 84. Kyowa Kirin Revenue in Stem Cell Therapy Business (US$ Million), 2021–2026
Table 85. Kyowa Kirin Recent Development
Table 86. CorestemChemon Inc. Company Details
Table 87. CorestemChemon Inc. Business Overview
Table 88. CorestemChemon Inc. Stem Cell Therapy Product
Table 89. CorestemChemon Inc. Revenue in Stem Cell Therapy Business (US$ Million), 2021–2026
Table 90. CorestemChemon Inc. Recent Development
Table 91. ANTEROGEN.CO., LTD. Company Details
Table 92. ANTEROGEN.CO., LTD. Business Overview
Table 93. ANTEROGEN.CO., LTD. Stem Cell Therapy Product
Table 94. ANTEROGEN.CO., LTD. Revenue in Stem Cell Therapy Business (US$ Million), 2021–2026
Table 95. ANTEROGEN.CO., LTD. Recent Development
Table 96. Holostem Company Details
Table 97. Holostem Business Overview
Table 98. Holostem Stem Cell Therapy Product
Table 99. Holostem Revenue in Stem Cell Therapy Business (US$ Million), 2021–2026
Table 100. Holostem Recent Development
Table 101. NuVasive Company Details
Table 102. NuVasive Business Overview
Table 103. NuVasive Stem Cell Therapy Product
Table 104. NuVasive Revenue in Stem Cell Therapy Business (US$ Million), 2021–2026
Table 105. NuVasive Recent Development
Table 106. JCR Pharmaceutical Company Details
Table 107. JCR Pharmaceutical Business Overview
Table 108. JCR Pharmaceutical Stem Cell Therapy Product
Table 109. JCR Pharmaceutical Revenue in Stem Cell Therapy Business (US$ Million), 2021–2026
Table 110. JCR Pharmaceutical Recent Development
Table 111. Pharmicell Company Details
Table 112. Pharmicell Business Overview
Table 113. Pharmicell Stem Cell Therapy Product
Table 114. Pharmicell Revenue in Stem Cell Therapy Business (US$ Million), 2021–2026
Table 115. Pharmicell Recent Development
Table 116. Medi-post Company Details
Table 117. Medi-post Business Overview
Table 118. Medi-post Stem Cell Therapy Product
Table 119. Medi-post Revenue in Stem Cell Therapy Business (US$ Million), 2021–2026
Table 120. Medi-post Recent Development
Table 121. Anterogen Company Details
Table 122. Anterogen Business Overview
Table 123. Anterogen Stem Cell Therapy Product
Table 124. Anterogen Revenue in Stem Cell Therapy Business (US$ Million), 2021–2026
Table 125. Anterogen Recent Development
Table 126. Takeda (TiGenix) Company Details
Table 127. Takeda (TiGenix) Business Overview
Table 128. Takeda (TiGenix) Stem Cell Therapy Product
Table 129. Takeda (TiGenix) Revenue in Stem Cell Therapy Business (US$ Million), 2021–2026
Table 130. Takeda (TiGenix) Recent Development
Table 131. Research Programs/Design for This Report
Table 132. Key Data Information from Secondary Sources
Table 133. Key Data Information from Primary Sources
Table 134. Authors List of This Report
List of Figures
Figure 1. Stem Cell Therapy Picture
Figure 2. Global Stem Cell Therapy Market Size Comparison by Type (US$ Million), 2021–2032
Figure 3. Global Stem Cell Therapy Market Share by Type: 2025 vs 2032
Figure 4. Allogeneic Stem Cell Therapies Features
Figure 5. Autologous Stem Cell Therapies Features
Figure 6. Global Stem Cell Therapy Market Size by Application (US$ Million), 2021–2032
Figure 7. Global Stem Cell Therapy Market Share by Application: 2025 vs 2032
Figure 8. Neurodegenerative Diseases Case Studies
Figure 9. Cardiovascular Disorders Case Studies
Figure 10. Autoimmune Conditions Case Studies
Figure 11. Orthopedic Injuries Case Studies
Figure 12. Cancer Case Studies
Figure 13. Others Case Studies
Figure 14. Stem Cell Therapy Report Years Considered
Figure 15. Global Stem Cell Therapy Market Size (US$ Million), Year-over-Year: 2021–2032
Figure 16. Global Stem Cell Therapy Market Size, (US$ Million), 2021 vs 2025 vs 2032
Figure 17. Global Stem Cell Therapy Market Share by Region: 2025 vs 2032
Figure 18. Global Stem Cell Therapy Market Share by Players in 2025
Figure 19. Global Stem Cell Therapy Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
Figure 20. The Top 10 and 5 Players Market Share by Stem Cell Therapy Revenue in 2025
Figure 21. North America Stem Cell Therapy Market Size YoY Growth (US$ Million), 2021–2032
Figure 22. North America Stem Cell Therapy Market Share by Country (2021–2032)
Figure 23. United States Stem Cell Therapy Market Size YoY Growth (US$ Million), 2021–2032
Figure 24. Canada Stem Cell Therapy Market Size YoY Growth (US$ Million), 2021–2032
Figure 25. Europe Stem Cell Therapy Market Size YoY Growth (US$ Million), 2021–2032
Figure 26. Europe Stem Cell Therapy Market Share by Country (2021–2032)
Figure 27. Germany Stem Cell Therapy Market Size YoY Growth (US$ Million), 2021–2032
Figure 28. France Stem Cell Therapy Market Size YoY Growth (US$ Million), 2021–2032
Figure 29. U.K. Stem Cell Therapy Market Size YoY Growth (US$ Million), 2021–2032
Figure 30. Italy Stem Cell Therapy Market Size YoY Growth (US$ Million), 2021–2032
Figure 31. Russia Stem Cell Therapy Market Size YoY Growth (US$ Million), 2021–2032
Figure 32. Ireland Stem Cell Therapy Market Size YoY Growth (US$ Million), 2021–2032
Figure 33. Asia-Pacific Stem Cell Therapy Market Size YoY Growth (US$ Million), 2021–2032
Figure 34. Asia-Pacific Stem Cell Therapy Market Share by Region (2021–2032)
Figure 35. China Stem Cell Therapy Market Size YoY Growth (US$ Million), 2021–2032
Figure 36. Japan Stem Cell Therapy Market Size YoY Growth (US$ Million), 2021–2032
Figure 37. South Korea Stem Cell Therapy Market Size YoY Growth (US$ Million), 2021–2032
Figure 38. Southeast Asia Stem Cell Therapy Market Size YoY Growth (US$ Million), 2021–2032
Figure 39. India Stem Cell Therapy Market Size YoY Growth (US$ Million), 2021–2032
Figure 40. Australia & New Zealand Stem Cell Therapy Market Size YoY Growth (US$ Million), 2021–2032
Figure 41. Latin America Stem Cell Therapy Market Size YoY Growth (US$ Million), 2021–2032
Figure 42. Latin America Stem Cell Therapy Market Share by Country (2021–2032)
Figure 43. Mexico Stem Cell Therapy Market Size YoY Growth (US$ Million), 2021–2032
Figure 44. Brazil Stem Cell Therapy Market Size YoY Growth (US$ Million), 2021–2032
Figure 45. Middle East & Africa Stem Cell Therapy Market Size YoY Growth (US$ Million), 2021–2032
Figure 46. Middle East & Africa Stem Cell Therapy Market Share by Country (2021–2032)
Figure 47. Israel Stem Cell Therapy Market Size YoY Growth (US$ Million), 2021–2032
Figure 48. Saudi Arabia Stem Cell Therapy Market Size YoY Growth (US$ Million), 2021–2032
Figure 49. UAE Stem Cell Therapy Market Size YoY Growth (US$ Million), 2021–2032
Figure 50. Medipost Revenue Growth Rate in Stem Cell Therapy Business (2021–2026)
Figure 51. Theracell Advanced Biotechnology Revenue Growth Rate in Stem Cell Therapy Business (2021–2026)
Figure 52. Nature Cell Revenue Growth Rate in Stem Cell Therapy Business (2021–2026)
Figure 53. Stempeutics Revenue Growth Rate in Stem Cell Therapy Business (2021–2026)
Figure 54. Regeneus Revenue Growth Rate in Stem Cell Therapy Business (2021–2026)
Figure 55. Bluebird bio, Inc Revenue Growth Rate in Stem Cell Therapy Business (2021–2026)
Figure 56. NIPRO Revenue Growth Rate in Stem Cell Therapy Business (2021–2026)
Figure 57. Kyowa Kirin Revenue Growth Rate in Stem Cell Therapy Business (2021–2026)
Figure 58. CorestemChemon Inc. Revenue Growth Rate in Stem Cell Therapy Business (2021–2026)
Figure 59. ANTEROGEN.CO., LTD. Revenue Growth Rate in Stem Cell Therapy Business (2021–2026)
Figure 60. Holostem Revenue Growth Rate in Stem Cell Therapy Business (2021–2026)
Figure 61. NuVasive Revenue Growth Rate in Stem Cell Therapy Business (2021–2026)
Figure 62. JCR Pharmaceutical Revenue Growth Rate in Stem Cell Therapy Business (2021–2026)
Figure 63. Pharmicell Revenue Growth Rate in Stem Cell Therapy Business (2021–2026)
Figure 64. Medi-post Revenue Growth Rate in Stem Cell Therapy Business (2021–2026)
Figure 65. Anterogen Revenue Growth Rate in Stem Cell Therapy Business (2021–2026)
Figure 66. Takeda (TiGenix) Revenue Growth Rate in Stem Cell Therapy Business (2021–2026)
Figure 67. Bottom-up and Top-down Approaches for This Report
Figure 68. Data Triangulation
Figure 69. Key Executives Interviewed
Table 1. Global Stem Cell Therapy Market Size Growth Rate by Type (US$ Million): 2021 vs 2025 vs 2032
Table 2. Key Players of Allogeneic Stem Cell Therapies
Table 3. Key Players of Autologous Stem Cell Therapies
Table 4. Global Stem Cell Therapy Market Size Growth by Application (US$ Million): 2021 vs 2025 vs 2032
Table 5. Global Stem Cell Therapy Market Size by Region (US$ Million): 2021 vs 2025 vs 2032
Table 6. Global Stem Cell Therapy Market Size by Region (US$ Million), 2021–2026
Table 7. Global Stem Cell Therapy Market Share by Region (2021–2026)
Table 8. Global Stem Cell Therapy Forecasted Market Size by Region (US$ Million), 2027–2032
Table 9. Global Stem Cell Therapy Market Share by Region (2027–2032)
Table 10. Stem Cell Therapy Market Trends
Table 11. Stem Cell Therapy Market Drivers
Table 12. Stem Cell Therapy Market Challenges
Table 13. Stem Cell Therapy Market Restraints
Table 14. Global Stem Cell Therapy Revenue by Players (US$ Million), 2021–2026
Table 15. Global Stem Cell Therapy Market Share by Players (2021–2026)
Table 16. Global Top Stem Cell Therapy Players by Tier (Tier 1, Tier 2, and Tier 3), based on Stem Cell Therapy Revenue, 2025
Table 17. Ranking of Global Top Stem Cell Therapy Companies by Revenue (US$ Million) in 2025
Table 18. Global 5 Largest Players Market Share by Stem Cell Therapy Revenue (CR5 and HHI), 2021–2026
Table 19. Global Key Players of Stem Cell Therapy, Headquarters and Area Served
Table 20. Global Key Players of Stem Cell Therapy, Products and Applications
Table 21. Global Key Players of Stem Cell Therapy, Date of General Availability (GA)
Table 22. Mergers and Acquisitions, Expansion Plans
Table 23. Global Stem Cell Therapy Market Size by Type (US$ Million), 2021–2026
Table 24. Global Stem Cell Therapy Revenue Market Share by Type (2021–2026)
Table 25. Global Stem Cell Therapy Forecasted Market Size by Type (US$ Million), 2027–2032
Table 26. Global Stem Cell Therapy Revenue Market Share by Type (2027–2032)
Table 27. Global Stem Cell Therapy Market Size by Application (US$ Million), 2021–2026
Table 28. Global Stem Cell Therapy Revenue Market Share by Application (2021–2026)
Table 29. Global Stem Cell Therapy Forecasted Market Size by Application (US$ Million), 2027–2032
Table 30. Global Stem Cell Therapy Revenue Market Share by Application (2027–2032)
Table 31. North America Stem Cell Therapy Market Size Growth Rate by Country (US$ Million): 2021 vs 2025 vs 2032
Table 32. North America Stem Cell Therapy Market Size by Country (US$ Million), 2021–2026
Table 33. North America Stem Cell Therapy Market Size by Country (US$ Million), 2027–2032
Table 34. Europe Stem Cell Therapy Market Size Growth Rate by Country (US$ Million): 2021 vs 2025 vs 2032
Table 35. Europe Stem Cell Therapy Market Size by Country (US$ Million), 2021–2026
Table 36. Europe Stem Cell Therapy Market Size by Country (US$ Million), 2027–2032
Table 37. Asia-Pacific Stem Cell Therapy Market Size Growth Rate by Region (US$ Million): 2021 vs 2025 vs 2032
Table 38. Asia-Pacific Stem Cell Therapy Market Size by Region (US$ Million), 2021–2026
Table 39. Asia-Pacific Stem Cell Therapy Market Size by Region (US$ Million), 2027–2032
Table 40. Latin America Stem Cell Therapy Market Size Growth Rate by Country (US$ Million): 2021 vs 2025 vs 2032
Table 41. Latin America Stem Cell Therapy Market Size by Country (US$ Million), 2021–2026
Table 42. Latin America Stem Cell Therapy Market Size by Country (US$ Million), 2027–2032
Table 43. Middle East & Africa Stem Cell Therapy Market Size Growth Rate by Country (US$ Million): 2021 vs 2025 vs 2032
Table 44. Middle East & Africa Stem Cell Therapy Market Size by Country (US$ Million), 2021–2026
Table 45. Middle East & Africa Stem Cell Therapy Market Size by Country (US$ Million), 2027–2032
Table 46. Medipost Company Details
Table 47. Medipost Business Overview
Table 48. Medipost Stem Cell Therapy Product
Table 49. Medipost Revenue in Stem Cell Therapy Business (US$ Million), 2021–2026
Table 50. Medipost Recent Development
Table 51. Theracell Advanced Biotechnology Company Details
Table 52. Theracell Advanced Biotechnology Business Overview
Table 53. Theracell Advanced Biotechnology Stem Cell Therapy Product
Table 54. Theracell Advanced Biotechnology Revenue in Stem Cell Therapy Business (US$ Million), 2021–2026
Table 55. Theracell Advanced Biotechnology Recent Development
Table 56. Nature Cell Company Details
Table 57. Nature Cell Business Overview
Table 58. Nature Cell Stem Cell Therapy Product
Table 59. Nature Cell Revenue in Stem Cell Therapy Business (US$ Million), 2021–2026
Table 60. Nature Cell Recent Development
Table 61. Stempeutics Company Details
Table 62. Stempeutics Business Overview
Table 63. Stempeutics Stem Cell Therapy Product
Table 64. Stempeutics Revenue in Stem Cell Therapy Business (US$ Million), 2021–2026
Table 65. Stempeutics Recent Development
Table 66. Regeneus Company Details
Table 67. Regeneus Business Overview
Table 68. Regeneus Stem Cell Therapy Product
Table 69. Regeneus Revenue in Stem Cell Therapy Business (US$ Million), 2021–2026
Table 70. Regeneus Recent Development
Table 71. Bluebird bio, Inc Company Details
Table 72. Bluebird bio, Inc Business Overview
Table 73. Bluebird bio, Inc Stem Cell Therapy Product
Table 74. Bluebird bio, Inc Revenue in Stem Cell Therapy Business (US$ Million), 2021–2026
Table 75. Bluebird bio, Inc Recent Development
Table 76. NIPRO Company Details
Table 77. NIPRO Business Overview
Table 78. NIPRO Stem Cell Therapy Product
Table 79. NIPRO Revenue in Stem Cell Therapy Business (US$ Million), 2021–2026
Table 80. NIPRO Recent Development
Table 81. Kyowa Kirin Company Details
Table 82. Kyowa Kirin Business Overview
Table 83. Kyowa Kirin Stem Cell Therapy Product
Table 84. Kyowa Kirin Revenue in Stem Cell Therapy Business (US$ Million), 2021–2026
Table 85. Kyowa Kirin Recent Development
Table 86. CorestemChemon Inc. Company Details
Table 87. CorestemChemon Inc. Business Overview
Table 88. CorestemChemon Inc. Stem Cell Therapy Product
Table 89. CorestemChemon Inc. Revenue in Stem Cell Therapy Business (US$ Million), 2021–2026
Table 90. CorestemChemon Inc. Recent Development
Table 91. ANTEROGEN.CO., LTD. Company Details
Table 92. ANTEROGEN.CO., LTD. Business Overview
Table 93. ANTEROGEN.CO., LTD. Stem Cell Therapy Product
Table 94. ANTEROGEN.CO., LTD. Revenue in Stem Cell Therapy Business (US$ Million), 2021–2026
Table 95. ANTEROGEN.CO., LTD. Recent Development
Table 96. Holostem Company Details
Table 97. Holostem Business Overview
Table 98. Holostem Stem Cell Therapy Product
Table 99. Holostem Revenue in Stem Cell Therapy Business (US$ Million), 2021–2026
Table 100. Holostem Recent Development
Table 101. NuVasive Company Details
Table 102. NuVasive Business Overview
Table 103. NuVasive Stem Cell Therapy Product
Table 104. NuVasive Revenue in Stem Cell Therapy Business (US$ Million), 2021–2026
Table 105. NuVasive Recent Development
Table 106. JCR Pharmaceutical Company Details
Table 107. JCR Pharmaceutical Business Overview
Table 108. JCR Pharmaceutical Stem Cell Therapy Product
Table 109. JCR Pharmaceutical Revenue in Stem Cell Therapy Business (US$ Million), 2021–2026
Table 110. JCR Pharmaceutical Recent Development
Table 111. Pharmicell Company Details
Table 112. Pharmicell Business Overview
Table 113. Pharmicell Stem Cell Therapy Product
Table 114. Pharmicell Revenue in Stem Cell Therapy Business (US$ Million), 2021–2026
Table 115. Pharmicell Recent Development
Table 116. Medi-post Company Details
Table 117. Medi-post Business Overview
Table 118. Medi-post Stem Cell Therapy Product
Table 119. Medi-post Revenue in Stem Cell Therapy Business (US$ Million), 2021–2026
Table 120. Medi-post Recent Development
Table 121. Anterogen Company Details
Table 122. Anterogen Business Overview
Table 123. Anterogen Stem Cell Therapy Product
Table 124. Anterogen Revenue in Stem Cell Therapy Business (US$ Million), 2021–2026
Table 125. Anterogen Recent Development
Table 126. Takeda (TiGenix) Company Details
Table 127. Takeda (TiGenix) Business Overview
Table 128. Takeda (TiGenix) Stem Cell Therapy Product
Table 129. Takeda (TiGenix) Revenue in Stem Cell Therapy Business (US$ Million), 2021–2026
Table 130. Takeda (TiGenix) Recent Development
Table 131. Research Programs/Design for This Report
Table 132. Key Data Information from Secondary Sources
Table 133. Key Data Information from Primary Sources
Table 134. Authors List of This Report
List of Figures
Figure 1. Stem Cell Therapy Picture
Figure 2. Global Stem Cell Therapy Market Size Comparison by Type (US$ Million), 2021–2032
Figure 3. Global Stem Cell Therapy Market Share by Type: 2025 vs 2032
Figure 4. Allogeneic Stem Cell Therapies Features
Figure 5. Autologous Stem Cell Therapies Features
Figure 6. Global Stem Cell Therapy Market Size by Application (US$ Million), 2021–2032
Figure 7. Global Stem Cell Therapy Market Share by Application: 2025 vs 2032
Figure 8. Neurodegenerative Diseases Case Studies
Figure 9. Cardiovascular Disorders Case Studies
Figure 10. Autoimmune Conditions Case Studies
Figure 11. Orthopedic Injuries Case Studies
Figure 12. Cancer Case Studies
Figure 13. Others Case Studies
Figure 14. Stem Cell Therapy Report Years Considered
Figure 15. Global Stem Cell Therapy Market Size (US$ Million), Year-over-Year: 2021–2032
Figure 16. Global Stem Cell Therapy Market Size, (US$ Million), 2021 vs 2025 vs 2032
Figure 17. Global Stem Cell Therapy Market Share by Region: 2025 vs 2032
Figure 18. Global Stem Cell Therapy Market Share by Players in 2025
Figure 19. Global Stem Cell Therapy Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
Figure 20. The Top 10 and 5 Players Market Share by Stem Cell Therapy Revenue in 2025
Figure 21. North America Stem Cell Therapy Market Size YoY Growth (US$ Million), 2021–2032
Figure 22. North America Stem Cell Therapy Market Share by Country (2021–2032)
Figure 23. United States Stem Cell Therapy Market Size YoY Growth (US$ Million), 2021–2032
Figure 24. Canada Stem Cell Therapy Market Size YoY Growth (US$ Million), 2021–2032
Figure 25. Europe Stem Cell Therapy Market Size YoY Growth (US$ Million), 2021–2032
Figure 26. Europe Stem Cell Therapy Market Share by Country (2021–2032)
Figure 27. Germany Stem Cell Therapy Market Size YoY Growth (US$ Million), 2021–2032
Figure 28. France Stem Cell Therapy Market Size YoY Growth (US$ Million), 2021–2032
Figure 29. U.K. Stem Cell Therapy Market Size YoY Growth (US$ Million), 2021–2032
Figure 30. Italy Stem Cell Therapy Market Size YoY Growth (US$ Million), 2021–2032
Figure 31. Russia Stem Cell Therapy Market Size YoY Growth (US$ Million), 2021–2032
Figure 32. Ireland Stem Cell Therapy Market Size YoY Growth (US$ Million), 2021–2032
Figure 33. Asia-Pacific Stem Cell Therapy Market Size YoY Growth (US$ Million), 2021–2032
Figure 34. Asia-Pacific Stem Cell Therapy Market Share by Region (2021–2032)
Figure 35. China Stem Cell Therapy Market Size YoY Growth (US$ Million), 2021–2032
Figure 36. Japan Stem Cell Therapy Market Size YoY Growth (US$ Million), 2021–2032
Figure 37. South Korea Stem Cell Therapy Market Size YoY Growth (US$ Million), 2021–2032
Figure 38. Southeast Asia Stem Cell Therapy Market Size YoY Growth (US$ Million), 2021–2032
Figure 39. India Stem Cell Therapy Market Size YoY Growth (US$ Million), 2021–2032
Figure 40. Australia & New Zealand Stem Cell Therapy Market Size YoY Growth (US$ Million), 2021–2032
Figure 41. Latin America Stem Cell Therapy Market Size YoY Growth (US$ Million), 2021–2032
Figure 42. Latin America Stem Cell Therapy Market Share by Country (2021–2032)
Figure 43. Mexico Stem Cell Therapy Market Size YoY Growth (US$ Million), 2021–2032
Figure 44. Brazil Stem Cell Therapy Market Size YoY Growth (US$ Million), 2021–2032
Figure 45. Middle East & Africa Stem Cell Therapy Market Size YoY Growth (US$ Million), 2021–2032
Figure 46. Middle East & Africa Stem Cell Therapy Market Share by Country (2021–2032)
Figure 47. Israel Stem Cell Therapy Market Size YoY Growth (US$ Million), 2021–2032
Figure 48. Saudi Arabia Stem Cell Therapy Market Size YoY Growth (US$ Million), 2021–2032
Figure 49. UAE Stem Cell Therapy Market Size YoY Growth (US$ Million), 2021–2032
Figure 50. Medipost Revenue Growth Rate in Stem Cell Therapy Business (2021–2026)
Figure 51. Theracell Advanced Biotechnology Revenue Growth Rate in Stem Cell Therapy Business (2021–2026)
Figure 52. Nature Cell Revenue Growth Rate in Stem Cell Therapy Business (2021–2026)
Figure 53. Stempeutics Revenue Growth Rate in Stem Cell Therapy Business (2021–2026)
Figure 54. Regeneus Revenue Growth Rate in Stem Cell Therapy Business (2021–2026)
Figure 55. Bluebird bio, Inc Revenue Growth Rate in Stem Cell Therapy Business (2021–2026)
Figure 56. NIPRO Revenue Growth Rate in Stem Cell Therapy Business (2021–2026)
Figure 57. Kyowa Kirin Revenue Growth Rate in Stem Cell Therapy Business (2021–2026)
Figure 58. CorestemChemon Inc. Revenue Growth Rate in Stem Cell Therapy Business (2021–2026)
Figure 59. ANTEROGEN.CO., LTD. Revenue Growth Rate in Stem Cell Therapy Business (2021–2026)
Figure 60. Holostem Revenue Growth Rate in Stem Cell Therapy Business (2021–2026)
Figure 61. NuVasive Revenue Growth Rate in Stem Cell Therapy Business (2021–2026)
Figure 62. JCR Pharmaceutical Revenue Growth Rate in Stem Cell Therapy Business (2021–2026)
Figure 63. Pharmicell Revenue Growth Rate in Stem Cell Therapy Business (2021–2026)
Figure 64. Medi-post Revenue Growth Rate in Stem Cell Therapy Business (2021–2026)
Figure 65. Anterogen Revenue Growth Rate in Stem Cell Therapy Business (2021–2026)
Figure 66. Takeda (TiGenix) Revenue Growth Rate in Stem Cell Therapy Business (2021–2026)
Figure 67. Bottom-up and Top-down Approaches for This Report
Figure 68. Data Triangulation
Figure 69. Key Executives Interviewed
Our team would be happy to assist you with your queries.
About us
Accurate data, The latest market trends, And deeper research directions.
Our sole purpose is to provide a basis for leaders in all walks of life to make more appropriate decisions, to help companies solve existing problems and achieve business goals
Latest reports
Global Ethylene Oxide (EO) Market Research Report 2026
Jan 17, 26
Global Stem Cells Cryopreservation Equipments Market Research Report 2026
Jan 17, 26
Global Selenium-enriched Yeast Market Research Report 2026
Jan 17, 26
Useful links
Our Contacts
Room 2306, T6 Fuxing World Financial Center, Kaifu District, Changsha, Hunan, China
(+86) 159 1069 5232